17th Annual Meeting of the American Society of Gene & Cell Therapy
May 21 – May 24, 2014 Washington, DC
17th Annual Meeting of the American Society of Gene & Cell Therapy
May 21 – May 24, 2014 Washington, DC
All You Need to Know About Irritable Bowel Syndrome in One Day
27th February 2014 Manchester, United Kingdom
We are delighted to invite you to this exciting CPD accredited conference presented by a panel of leading international experts on IBS.
Irritable Bowel Syndrome is a common functional disorder with high reported prevalence rates throughout the world. However it is often misunderstood and misdiagnosed. Although diet is important in this condition, a whole variety of other factors are involved in the production of symptoms and a full understanding of these can result in more effective management resulting in greater patient satisfaction.
This conference will bring together a group of top clinicians, scientists and researchers with an interest in IBS and other functional GI disorders to foster greater awareness of IBS, and update existing knowledge resulting in All You Need to Know About Irritable Bowel Syndrome in One Day.
This conference will be held on the 27th of February 2014 at the Hilton Manchester Deansgate hotel and is of great relevance to practicing gastroenterologists, general practitioners and doctors in training, counselors, occupational therapists, nurses and paediatricians, primary care physicians, psychologists, sociologists, and other health care providers interested in a complete update on IBS, scientists and academicians interested in investigation of these conditions, members of health policy and regulatory organisations.
Topics will include
Patterns, Prevalence and Perceptions in IBS
Intestinal microbiota in IBS, including the role of pre-, pro- and antibiotics
Incorporating new diagnostics and drugs in to IBS management
The dietary management of irritable bowel syndrome
How do intestinal abnormalities in IBS link to symptoms
Mechanisms of visceral pain in IBS
Hypnosis for IBS.. What's it all about?
Plenary sessions will be interspersed with questions and answer sessions and panel discussions. The meeting represents a valuable opportunity to network, share knowledge and ideas, and consider collaborative projects.
Mycobacterium Tuberculosis Infection Treatment
Wednesday, 26 March 2014 09:00 - 17:00 London, United Kingdom
This event will look at discovering and producing new antibiotics to combat tuberculosis. The conference will discuss target and compound discovery, new potential anti-TB compounds in development, clinical trial design and early trial results. We invite researchers interested in all aspects of drug development and welcome participants from academia, industry, government and non-governmental organizations.
This event is part of the 2014 TB Summit - www.TBSummit2014.com
Phone: 07507 799380
2014 - Exploiting Bacteriophages for Bioscience, Biotechnology and Medicine (the 5th in a Biennial Series)
Thursday, 23 January 2014 09:00 - 17:00 London, United Kingdom
Bacteriophages (phages) are arguably the most abundant biological entities on the planet. They play crucial roles in driving the adaptive evolution of their bacterial hosts, and achieve this both through the predator-prey roles of the phage-bacterium interaction and through the adaptive impacts of lysogeny and lysogenic conversion. Bacteriophages are the source of many biochemical reagents and technologies, indispensible for modern molecular biology. Furthermore, phages are being exploited in other areas of biotechnology, including diagnostics, prophylaxis and other aspects of food microbiology. In recent years there has been a growing interest in developing phages for therapeutic purposes (phage therapy) as natural alternatives to antibiotics. The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the disappointingly low rate of emergence of new, clinically useful antibiotics, has refocused attention on the potential utility of phages for treating human and animal disease. Examples of the roles of phages in fundamental biological research and in medical and industrial biotechnologies will be discussed at this meeting. On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event.
This event has CPD accreditation and will have a discussion panel session.
EASL Monothematic Conference: Molecular Pathogenesis & Translational Research in Liver Cancer
February 13-15, 2014 Geneva, Switzerland
Hepatocellular carcinoma is the third leading cause of cancer related to death and shows worldwide increase in incidence with being the most rapidly increasing cancer in several western world countries. In order to improve understanding of its molecular pathogenesis and provide the basis for further and more successful therapeutic approaches it is mandatory to foster basic biomedical research in hepatocellular carcinoma. While there are many conferences addressing clinical aspects of liver cancer there is an obvious lack of adequate research conferences, the EASL Monothematic Conference will address all relevant areas of current basic research in hepatocarcinogenesis; it will bring together the leading researchers with junior scientists interested in and devoted to liver cancer research and provide sufficient time for discussion around oral presentations and poster sessions.
Provide an adequate forum for leading and junior liver cancer researchers for data presentation and discussion
Update participants on status and recent achievements in liver cancer research
Outline implications of liver cancer research findings for translational research and new concepts for clinical application
Further develop the existing concepts of molecular classification of HCC and explore the potential for predictive diagnostics.
By active participation in the EASL Basic Monothematic Conference 'Molecular Pathogenesis and Translational Research in Liver Cancer' profound knowledge in the following objectives will be gained:
profound knowledge about the molecular etiology of human liver cancer, specifically how the major chronic liver diseases induce HCC and potential to perform secondary prevention in patients at risk
detailed information about the relevant molecular changes occuring in human HCC and its precursor lesions
protumorigenic molecular mechanisms leading to human HCC, their functional interaction, and means of therapeutic interference
novel therapeutic strategies currently under preclinical development or in early clinical trials
potential for predictive molecular testing in liver cancer
International Society for Stem Cell Research 12th Annual Meeting
June 18-21, 2014 Vancouver, Canada
Clinical Translation of Stem Cells 2014
April 21-22, 2014 Palm Springs California
SELECTBIO Clinical Translation of Stem Cells 2014 brings together basic scientists, clinician-scientists, as well as medical practitioners/surgeons focusing on studying, characterizing, and deploying various classes of stem cells for therapeutic utility.
In addition to top-tier presentations during this conference, SELECTBIO has also partnered with surgeons and surgery centers in the Palm Springs area to offer conference delegates a "hands-on" Clinical Practicum providing conference delegates the ability to observe in real-time adipose tissue extraction and processing ex vivo. This "hands-on" demonstration led by leading surgeons in the field is in full compliance with applicable laws and regulations and performed by board-certified surgeons.
This conference therefore provides valuable learning and networking experiences for both basic researchers and clinicians alike seeking the most up-to-date information, protocols, and products in this emerging field.
All delegates are automatically registered to the Clinical Practicum which will be conducted in the evening after the conclusion of the conference presentations.
• Adipose-derived Stem Cells
• Clinical Utility
• Disease Classes Addressed and Current Status of Ongoing Clinical Trials
• Regulatory Landscape and Ethical Considerations
• Research and Clinical Perspectives
◦ Cosmetic Surgery and Associated Applications
◦ Regenerative Medicine
• Translational Research Activities with Adult Stem Cells
• Umbilical Cord Blood-derived Stem Cells
This Conference and Associated Clinical Practicum is Ideally Suited for the Following Audiences:
• Basic Researchers Seeking to Drive their Innovations towards Translational/Clinical Applications
• Cosmetic Surgeons, Surgeons Seeking to Understand the Regenerative Medicine/Stem Cells Space
• Attorneys, Investors, Regulatory Agency Professionals Seeking Clarity in the Regenerative Medicine/Stem Cell Therapy Field
Wednesday 30 April - Saturday 3 May 2014 Heidelberg, Germany
This EMBO | EMBL Symposium aims to bring together established experts, physician scientists and basic researchers to discuss the multi-layered and complex processes leading up to novel therapeutic strategies for diabetes, obesity and related health issues, such as cancer and cardiovascular disease.
11th Annual International Symposium of Ultrasound for Regional Anesthesia, Pain Medicine and Perioperative Applications (ISURA)
June 21-24, 2014 Toronto, Canada
The ISURA 2014 scientific program has included distinguished national and international guest faculty and University of Toronto faculty. There will be:
2 days of lectures and hands on workshops for regional anesthesia
2 days for pain medicine and MSK imaging
½ day of cadaver workshop for pain medicine (optional)
2 days for peri-operative application
Both basic and advanced procedures will be discussed. There will be plenty of time for panel discussion, group scanning, and hands on practice on live subjects, pig carcass, and phantom simulators.
By the end of the conference, the participants will be able to:
Describe the basic principles of ultrasound guided regional anesthesia and interventional pain procedures.
Identify proper approaches to image nerve and musculoskeletal structures and insert needle.
Critically interpret images of nerve, vessels and musculoskeletal structures including anatomical variants and artifacts.
Develop the cognitive and practical skills on the use of ultrasound for regional anesthesia and interventional pain procedures.
Develop a practical understanding of MSK imaging for pain evaluation.
Understand the utility of ultrasound for perioperative applications.
All in all, this conference is designed to provide anesthesiologists and pain practitioners a comprehensive review of ultrasound imaging for regional anesthesia, pain medicine (diagnosis and intervention) and perioperative medicine. Our panel of international and national renowned faculty will provide you with the latest developments and state-of-the-art information in the world of ultrasound.
16th Biennial Meeting of the European Society for Immunodeficiencies (ESID 2014)
29 October – 1 November, 2014 Prague, Czech Republic
The 16th Biennial Meeting of the European Society for Immunodeficiencies (ESID 2014), being held in the enchanting city of Prague, Czech Republic, offers unparalleled access to the latest research and analysis in the field. Meeting participants will gain valuable insights into innovative perspectives in both basic and clinical research. The scientific programme will draw together experts from around the world to discuss breakthroughs in diagnostic immunology, genetics and immunobiology of human diseases, advances in clinical practice, novel therapeutic approaches to tolerance induction and new insights into stem-cell and cellular therapies.
An ideal forum to share knowledge, connect with professional colleagues and grow your professional network, ESID 2014 is being held 29 October – 1 November, 2014.